-
September 18, 2018PREVIEW
Patients with cancer who used complementary medicines had higher refusal rates of surgery, chemotherapy, radiotherapy, and hormone therapy compared with those who did not use these alternative...
-
August 28, 2018PREVIEW
Two trials published in the New England Journal of Medicine showed that use of the next-generation androgen-receptor blockers apalutamide (Erleada—Janssen) or enzalutamide (Xtandi—...
-
June 11, 2018PREVIEW
An observational analysis assessing trends in costs of anticancer drugs over a 10-year period compared with clinical benefits in the Journal of Oncology Practice found that monthly prices...
-
March 27, 2018PREVIEW
A single infusion of tisagenlecleucel (Kymriah—Novartis) administered to pediatric patients and young adults with B-cell acute lymphoblastic leukemia (ALL) resulted in a highly durable remission...
-
December 18, 2017PREVIEW
Two pivotal trials published in the New England Journal of Medicine show that adjuvant therapy with dabrafenib (Tafinlar—Novartis) plus trametinib (Mekinist—Novartis) for patients with...
Pages
